Hyperprolactinemia: Clinical Trials

2 trials for Hyperprolactinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
Amantadine Hydrochloride, USP, Placebo - Schizophrenia, Schizoaffective Disorder
Phase 4TerminatedDavid C. Henderson, MD62009-10-012013-06-10
The Luveris In Vitro Fertilization Trial
Luveris fixed dose, Luveris increasing dose - Infertility, Hypothalamic Amenorrhea
Phase 4TerminatedUniversity Reproductive Associates142009-04-012018-08-07

Narrower conditions

Infertility (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Endocrine System Diseases (2)  ·  Hyperpituitarism (2)  ·  Hypothalamic Diseases (2)  ·  Nervous System Diseases (2)  ·  Pituitary Diseases (2)  ·  Genital Diseases (1)  ·  Mental Disorders (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Urogenital Diseases (1)

Interventions

Amantadine (1)  ·  Luteinizing Hormone, beta Subunit (1)

Sponsors

David C. Henderson, MD (1)  ·  University Reproductive Associates (1)

Countries

United States (2)

Top investigators

David C. Henderson, M.D. (1)